Loyal
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
548 Market St Pmb 26099, San Francisco, ...Website
www.loyal.comRevenue
$42.3 MillionIndustry
About Loyal
Loyal Org Chart
Is Loyal your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Loyal, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Loyal
Click to see if Loyal had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Loyal has new funding data
Product Launch: Get notified when Loyal launches new products
Check out if Loyal is spiking on competitors!
Earning: See what the market has to say on Loyal recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Loyal has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Loyal
Find 3 more new buyers
Company Profile Activity
Activity Insights
Loyal is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Loyal is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Loyal.
Loyal financials insights
Gather financial insights about Loyal, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Unspecified
$11M
Series A
$27M
Series B
$45M
Series C
$100M
Loyal Tech Stack
A closer look at the technologies used by Loyal
Most Recent Scoops
Loyal News & Media
Loyal Announces $45 Million Series B Financing to Continue Development of First FDA-Approved Dog Lifespan Extension Drug for Veterinary Use
SAN FRANCISCO--(BUSINESS WIRE)-- #funding--Loyal, a biotech company pioneering longevity drugs for dogs, announced it has successfully completed its Series B funding round of $45 million.Loyal Launches Nationwide, 1,000-Dog Clinical Trial for Drug to Extend Healthy Lifespan in Senior Dogs
SAN FRANCISCO--(BUSINESS WIRE)--Biotech company Loyal launches nationwide, 1,000-dog clinical trial for its LOY-002 drug to extend healthy lifespan in senior dogs.FDA Agrees Loyal Data Supports Reasonable Expectation of Effectiveness for Large Dog Lifespan Extension
SAN FRANCISCO--(BUSINESS WIRE)-- #LoyalGetsRXE--The FDA has accepted Loyal's Reasonable Expectation of Effectiveness application for LOY-001, a drug to help large- and giant-breed dogs live longer.An anti-aging drug for dogs promises to win owners more time with old pets. It could be FDA-approved soon.
There has never been a longevity drug approved by the FDA. Loyal for Dogs founder Celine Halioua is close to changing that.
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Loyal
Loyal is a clinical stage animal health company working to help dogs live longer and stay healthier as they age. The team develops preventive veterinary medicines that target underlying drivers of aging in different breeds. Loyal partners with veterinarians and dog owners to turn cutting edge research into everyday care.... Read More